The Effect of Universal Influenza Immunization on Mortality and Health Care Use

October 20, 2008

Please describe the reason for abuse:

Peer-Reviewed Paper, View Original
Background In 2000, Ontario, Canada, initiated a universal influenza immunization program (UIIP) to provide free influenza vaccines for the... » More
PLoS Med. 2008 Oct 28; 5(10):e211
Jeffrey c. Kwong, Thérèse a. Stukel, Jenny Lim, Allison j. Mcgeer, Ross e.g. Upshur, Helen Johansen, Christie Sambell, William w. Thompson, Deva Thiruchelvam, Fawziah Marra, Lawrence w. Svenson, Douglas g. Manuel

Belongs to:

Loading comments
  1. Nichol KL (2003) The efficacy, effectiveness and cost-effectiveness of inactivated influenza virus vaccines. Vaccine 21: 1769-1775.
  2. Rivetti D, Jefferson T, Thomas R, Rudin M, Rivetti A (2006) Vaccines for preventing influenza in the elderly. Cochrane Database Syst Rev 3: CD004876.
  3. Nichol KL, Nordin JD, Nelson DB, Mullooly JP, Hak E (2007) Effectiveness of influenza vaccine in the community-dwelling elderly. N Engl J Med 357: 1373-1381.
  4. Jefferson TO, Rivetti D, Di PC, Rivetti A, Demicheli V (2007) Vaccines for preventing influenza in healthy adults. Cochrane Database Syst RevCD001269..
  5. Jefferson T, Rivetti A, Harnden A, Di Pietrantonj C, Demicheli V (2008) Vaccines for preventing influenza in healthy children. Cochrane Database Syst RevCD004879..
  6. Simonsen L, Reichert TA, Viboud C, Blackwelder WC, Taylor RJ (2005) Impact of influenza vaccination on seasonal mortality in the US elderly population. Arch Intern Med 165: 265-272.
  7. Jackson LA, Jackson ML, Nelson JC, Neuzil KM, Weiss NS (2006) Evidence of bias in estimates of influenza vaccine effectiveness in seniors. Int J Epidemiol 35: 337-344.
  8. Simonsen L, Taylor RJ, Viboud C, Miller MA, Jackson LA (2007) Mortality benefits of influenza vaccination in elderly people: an ongoing controversy. Lancet Infect Dis 7: 658-666.
  9. Jackson ML, Nelson JC, Weiss NS, Neuzil KM, Barlow W (2008) Influenza vaccination and risk of community-acquired pneumonia in immunocompetent elderly people: a population-based, nested case-control study. Lancet 372: 398-405.
  10. Fiore AE, Shay DK, Haber P, Iskander JK, Uyeki TM (2007) Prevention and control of influenza. Recommendations of the Advisory Committee on Immunization Practices (ACIP), 2007. MMWR Recomm Rep 56: 1-54.
  11. (2007) Statement on influenza vaccination for the 2007–2008 season. An Advisory Committee Statement (ACS). Can Commun Dis Rep 33: 1-38.
  12. (2000 July 25) . Ontario invests $38 million to ease emergency room pressures with universal vaccination programAvailable:
  13. Schabas RE (2001) Mass influenza vaccination in Ontario: a sensible move. Can Med Assoc J 164: 36-37.
  14. Demicheli V (2001) Mass influenza vaccination in Ontario: is it worthwhile. Can Med Assoc J 164: 38-39.
  15. Kwong JC, Rosella LC, Johansen H (2007) Trends in influenza vaccination in Canada, 1996/97 to 2005. Health Rep 18: 1-11.
  16. Last JM (2001) . A dictionary of epidemiologyOxford University Press. New York.
  17. Beland Y (2002) Canadian community health survey–methodological overview. Health Rep 13: 9-14.
  18. Tambay JL, Catlin G (1995) Sample design of the national population health survey. Health Rep 7: 29-38.
  19. Johansen H, Nguyen K, Mao L, Marcoux R, Gao R (2004) Influenza vaccination. Health Rep 15: 33-43.
  20. Johansen H, Sambell C, Zhao H (2006) Flu shots - national and provincial/territorial trends. Health Rep 17: 49-54.
  21. Kwong JC, Sambell C, Johansen H, Stukel TA, Manuel DG (2006) The effect of universal influenza immunization on vaccination rates in Ontario. Health Rep 17: 31-40.
  22. Lui KJ, Kendal AP (1987) Impact of influenza epidemics on mortality in the United States from October 1972 to May 1985. Am J Public Health 77: 712-716.
  23. Simonsen L, Clarke MJ, Williamson GD, Stroup DF, Arden NH (1997) The impact of influenza epidemics on mortality: introducing a severity index. Am J Public Health 87: 1944-1950.
  24. (2005) . Improving health care data in Ontario: ICES investigative report to the Ontario Ministry of Health and Long-Term CareInstitute for Clinical Evaluative Sciences. Toronto.
  25. McCullagh P, Nelder JA (1989) . Generalized linear modelsChapman and Hall. New York.
  26. Thompson WW, Shay DK, Weintraub E, Brammer L, Cox N (2003) Mortality associated with influenza and respiratory syncytial virus in the United States. JAMA 289: 179-186.
  27. Thompson WW, Shay DK, Weintraub E, Brammer L, Bridges CB (2004) Influenza-associated hospitalizations in the United States. JAMA 292: 1333-1340.
  28. Rothman KJ (1998) . Modern epidemiologyLippincott-Raven. Philadelphia.
  29. Anderson RN, Minino AM, Hoyert DL, Rosenberg HM (2001) Comparability of cause of death between ICD-9 and ICD-10: preliminary estimates. Natl Vital Stat Rep 49: 1-32.
  30. (2005) Influenza in Canada: 2003–2004 season. Can Commun Dis Rep 31: 1-18.
  31. Gaglani MJ, Piedra PA, Herschler GB, Griffith ME, Kozinetz CA (2004) Direct and total effectiveness of the intranasal, live-attenuated, trivalent cold-adapted influenza virus vaccine against the 2000–2001 influenza A(H1N1) and B epidemic in healthy children. Arch Pediatr Adolesc Med 158: 65-73.
  32. Menec VH, Black C, MacWilliam L, Aoki FY (2003) The impact of influenza-associated respiratory illnesses on hospitalizations, physician visits, emergency room visits, and mortality. Can J Public Health 94: 59-63.
  33. (2006) Influenza in Canada–2004–2005 season. Can Commun Dis Rep 32: 57-74.
  34. Dushoff J, Plotkin JB, Viboud C, Earn DJ, Simonsen L (2006) Mortality due to influenza in the United States–an annualized regression approach using multiple-cause mortality data. Am J Epidemiol 163: 181-187.
  35. Groll DL, Thomson DJ (2006) Incidence of influenza in Ontario following the Universal Influenza Immunization Campaign. Vaccine 24: 5245-5250.
  36. Kwong JC, Stukel TA, McGeer AJ, Manuel DG (2007) Appropriate measures of influenza immunization program effectiveness. Vaccine 25: 967-969.
  37. Goodwin K, Viboud C, Simonsen L (2006) Antibody response to influenza vaccination in the elderly: a quantitative review. Vaccine 24: 1159-1169.
  38. Vallejo AN (2007) Immune remodeling: lessons from repertoire alterations during chronological aging and in immune-mediated disease. Trends Mol Med 13: 94-102.
  39. Kang I, Hong MS, Nolasco H, Park SH, Dan JM (2004) Age-associated change in the frequency of memory CD4+ T cells impairs long term CD4+ T cell responses to influenza vaccine. J Immunol 173: 673-681.
  40. Goronzy JJ, Fulbright JW, Crowson CS, Poland GA, O'Fallon WM (2001) Value of immunological markers in predicting responsiveness to influenza vaccination in elderly individuals. J Virol 75: 12182-12187.
  41. Bridges CB, Thompson WW, Meltzer MI, Reeve GR, Talamonti WJ (2000) Effectiveness and cost-benefit of influenza vaccination of healthy working adults: A randomized controlled trial. JAMA 284: 1655-1663.
  42. Mogabgab WJ, Leiderman E (1970) Immunogenicity of 1967 polyvalent and 1968 Hong Kong influenza vaccines. JAMA 211: 1672-1676.
  43. Monto AS, Davenport FM, Napier JA, Francis T (1970) Modification of an outbreak of influenza in Tecumseh, Michigan by vaccination of schoolchildren. J Infect Dis 122: 16-25.
  44. Reichert TA, Sugaya N, Fedson DS, Glezen WP, Simonsen L (2001) The Japanese experience with vaccinating schoolchildren against influenza. N Engl J Med 344: 889-896.
  45. Piedra PA, Gaglani MJ, Kozinetz CA, Herschler G, Riggs M (2005) Herd immunity in adults against influenza-related illnesses with use of the trivalent-live attenuated influenza vaccine (CAIV-T) in children. Vaccine 23: 1540-1548.
  46. Weycker D, Edelsberg J, Halloran ME, Longini IM, Nizam A (2005) Population-wide benefits of routine vaccination of children against influenza. Vaccine 23: 1284-1293.
  47. Metlay JP, Fishman NO, Joffe M, Edelstein PH (2006) Impact of pediatric vaccination with pneumococcal conjugate vaccine on the risk of bacteremic pneumococcal pneumonia in adults. Vaccine 24: 468-475.
  48. Grijalva CG, Nuorti JP, Arbogast PG, Martin SW, Edwards KM (2007) Decline in pneumonia admissions after routine childhood immunisation with pneumococcal conjugate vaccine in the USA: a time-series analysis. Lancet 369: 1179-1186.
Copyright 2013 © Jeffrey c. Kwong, Thérèse a. Stukel, Jenny Lim, Allison j. Mcgeer, Ross e.g. Upshur, Helen Johansen, Christie Sambell, William w. Thompson, Deva Thiruchelvam, Fawziah Marra, Lawrence w. Svenson, Douglas g. Manuel. This pubcast is licensed under the terms of the Creative Commons Attribution License 3.0, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.